CoChat
Cited by 170

The DOI matches its Crossref record.

Thalidomide for the Treatment of Uremic Pruritus: A Crossover Randomized Double-Blind Trial

Silva, Sandra R.B., Viana, Pedro C.F., Lugon, Nilza V., Hoette, Marcos, Ruzany, Frederico, Lugon, Jocemir R. · 1994 · Nephron

Abstract

Our observation that thalidomide administration to a dialysis patient with leprosy alleviated his pruritus led us to conduct this short-term study to assess the efficacy of the drug in this regard. From 210 hemodialysis patients, 29 cases of refractory uremic pruritus were entered into the study. Patients were instructed to score their symptoms from 0 to 3, three times a day and assigned to receive thalidomide or placebo at bed time for 7 days. After a washout period of 7 days, drugs were crossed over. Response was defined as a reduction of at least 50% in the pruritus scoring. Eighteen patients finished the study. In the first phase, 55% of patients responded showing a mean reduction in their pruritus scoring of 78% (p < 0.05 vs. placebo); no response to placebo was observed. A similar proportion of patients responded to thalidomide in the second phase with a mean reduction in their pruritus scoring of 81%. In conclusion, thalidomide can be a precious tool in the handling of uremic pruritus unresponsive to available therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1159/000187978

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 170

Metadata

Authors
Silva, S. R. B., Viana, P. C. F., Lugon, N. V., Hoette, M., Ruzany, F., & Lugon, J. R.
Venue
Nephron
Publisher
S. Karger AG
Published
1994
Volume
67
Issue
3
Pages
270-273
ISSN
  • 1660-8151 (ISSN-L)
  • 2235-3186
OpenAlex
W1999272370
Cited by
170
References
0
FWCI
5.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thalidomide for the Treatment of Uremic Pruritus: A Crossover Randomized Double-Blind Trial. https://app.cochat.ai/papers/10.1159/000187978
The paper
Silva, S. R. B., Viana, P. C. F., Lugon, N. V., Hoette, M., Ruzany, F., & Lugon, J. R. (1994). Thalidomide for the Treatment of Uremic Pruritus: A Crossover Randomized Double-Blind Trial. Nephron. https://doi.org/10.1159/000187978

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.